{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:44:44Z","timestamp":1791078284492,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.ejphar.2005.12.079","type":"journal-article","created":{"date-parts":[[2006,2,22]],"date-time":"2006-02-22T07:25:10Z","timestamp":1140593110000},"page":"270-278","source":"Crossref","is-referenced-by-count":19,"title":["Effects of cyamemazine on hERG, INa, ICa, Ito, Isus and IK1 channel currents, and on the QTc interval in guinea pigs"],"prefix":"10.1016","volume":"532","author":[{"given":"William","family":"Crumb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Michel","family":"Llorca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Lancon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George P.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo P.","family":"Garay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahc\u00e8ne","family":"Hameg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2005.12.079_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/sj.bjp.0701402","article-title":"Comparison of the acute cardiotoxicity of the antimalarial drug halofantrine in vitro and in vivo in anaesthetized guinea-pigs","volume":"122","author":"Batey","year":"1997","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.079_bib2","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1517\/14740338.4.3.509","article-title":"ICH S7B draft guideline on the non-clinical strategy for testing delayed cardiac repolarisation risk of drugs: a critical analysis","volume":"4","author":"Cavero","year":"2005","journal-title":"Expert Opin. Drug Safety"},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2005.12.079_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00002018-199921001-00004","article-title":"Preclinical in vitro cardiac electrophysiology: a method of predicting arrhythmogenic potential of antihistamines in humans","volume":"21","author":"Cavero","year":"1999","journal-title":"Drug Safety"},{"key":"10.1016\/j.ejphar.2005.12.079_bib4","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1517\/14656566.1.5.947","article-title":"Drugs that prolong QT interval as an unwanted effect: assessing their likelihood of inducing hazardous cardiac dysrhythmias","volume":"1","author":"Cavero","year":"2000","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejphar.2005.12.079_bib5","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1182\/blood-2002-02-0598","article-title":"Prolongation of cardiac repolarization by arsenic trioxide","volume":"100","author":"Chiang","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejphar.2005.12.079_bib6","series-title":"Current Protocols in Pharmacology","first-page":"10.8.1","article-title":"Patch-clamp studies of human cardiac ion channels in the evaluation of cardiac electrophysiological effects of compounds","author":"Crumb","year":"2003"},{"key":"10.1016\/j.ejphar.2005.12.079_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1046\/j.1472-8206.2002.00081.x","article-title":"In vivo measurement of QT prolongation, dispersion and arrhythmogenesis: application to the preclinical cardiovascular safety pharmacology of a new chemical entity","volume":"16","author":"De Clerck","year":"2002","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.079_bib8","first-page":"62","article-title":"Antipsychotiques et s\u00e9curit\u00e9 cardio-vasculaire: donn\u00e9es actuelles sur les allongements de l'intervalle QT et le risque d'arythmies ventriculaires","volume":"26","author":"Gury","year":"2000","journal-title":"L'Enc\u00e9phale"},{"key":"10.1016\/j.ejphar.2005.12.079_bib9","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0006-2952(02)01515-0","article-title":"Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes","volume":"65","author":"Hameg","year":"2003","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.079_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/toxsci\/kfg254","article-title":"QT and RR intervals in conscious and anesthetized guinea pigs with highly varying RR intervals and given QTc-lengthening test articles","volume":"76","author":"Hamlin","year":"2003","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.ejphar.2005.12.079_bib11","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/1056-8719(94)90088-4","article-title":"Comparison of the acute cardiotoxicity of the antimalarial drug. Relationship between QaT and RR intervals in rats, guinea pigs, rabbits","volume":"32","author":"Hayes","year":"1994","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.ejphar.2005.12.079_bib12","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-7793.1998.003bi.x","article-title":"Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels","volume":"511","author":"Herzberg","year":"1998","journal-title":"J. Physiol."},{"key":"10.1016\/j.ejphar.2005.12.079_bib13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1592\/phco.21.9.871.34565","article-title":"Torsades de pointes associated with chlorpromazine: case report and review of associated ventricular arrhythmias","volume":"21","author":"Hoehns","year":"2001","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejphar.2005.12.079_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1254\/jjp.76.31","article-title":"Inhibition of delayed rectifier K+ current by dofetilide and E-4031 differentially affects electrical cardiac responses to vagus stimulation in anesthetized dogs","volume":"76","author":"Imamura","year":"1998","journal-title":"Jpn. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.079_bib15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1124\/jpet.103.062182","article-title":"Cardiac ion channel effects of tolterodine","volume":"308","author":"Kang","year":"2004","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2005.12.079_bib16","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1034\/j.1600-0773.2001.d01-142.x","article-title":"Effects of 5-HT(4) receptor agonists, cisapride and mosapride citrate on electrocardiogram in anaesthetized rats and guinea-pigs and conscious cats","volume":"89","author":"Kii","year":"2001","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2005.12.079_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0014-2999(02)02074-5","article-title":"A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs","volume":"450","author":"Kongsamut","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.079_bib18","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S0140-6736(97)26018-6","article-title":"Risks of non-sedating antihistamines","volume":"349","author":"Lindquist","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2005.12.079_bib19","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1023\/A:1014460404352","article-title":"Quantitative relationship between myocardial concentration of tacrolimus and QT prolongation in guinea pigs: pharmacokinetic\/pharmacodynamic model incorporating a site of adverse effect","volume":"28","author":"Minematsu","year":"2001","journal-title":"J. Pharmacokinet. Pharmacodyn."},{"key":"10.1016\/j.ejphar.2005.12.079_bib20","first-page":"967","article-title":"Cyam\u00e9mazine: traitement symptomatique des dimensions anxieuses, impulsives et agressives","volume":"vol. 10","author":"Radat","year":"1995"},{"key":"10.1016\/j.ejphar.2005.12.079_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0008-6363(02)00846-5","article-title":"Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development","volume":"58","author":"Redfern","year":"2003","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ejphar.2005.12.079_bib22","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2337\/diabetes.45.9.1197","article-title":"Efficient gene transfer to dispersed human pancreatic islet cells in vitro using adenovirus-polylysine\/DNA complexes or polycationic liposomes","volume":"45","author":"Saldeen","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2005.12.079_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1536\/ihj.39.183","article-title":"Effect of E4031, a class III antiarrhythmic drug, on ischemia- and reperfusion-induced arrhythmias in isolated rat hearts","volume":"39","author":"Shinmura","year":"1998","journal-title":"Jpn. Heart J."},{"key":"10.1016\/j.ejphar.2005.12.079_bib24","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0705283","article-title":"The antipsychotic drug chlorpromazine inhibits HERG potassium channels","volume":"139","author":"Thomas","year":"2003","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2005.12.079_bib25","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1600-0447.1996.tb10653.x","article-title":"Electrocardiographic changes in patients receiving neuroleptic medication","volume":"93","author":"Warner","year":"1996","journal-title":"Acta Psychiatr. Scand."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905013051?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299905013051?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,18]],"date-time":"2019-01-18T05:20:22Z","timestamp":1547788822000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299905013051"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0014299905013051"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2005.12.079","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}